Purchase Order 75F40124P00216
Award Date 6/10/24
Potential Completion Date 9/30/24
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) has awarded a $39,657.00 firm fixed-price delivery order to Pacific Biosciences of California, Inc. (PacBio) under the company's existing $1 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the agency. This delivery order is for the purchase of specific supplies and reagents to support the agency's use of PacBio's Sequel IIe long-read DNA/RNA sequencing platform. The award, made without a set-aside designation, is the latest task...
- This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...
- This federal contract, awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., is for the procurement of PACBIO REAGENTS. The contract has a ceiling value of $24,357.60 and is a firm fixed price purchase order with a performance period ending on September 30, 2024. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are widely used by federal agencies for genomic research and regulatory...
- This federal contract award to Pacific Biosciences of California, Inc. is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract #75F40121D00007 with the Food and Drug Administration (FDA). The purpose is to purchase specific supplies and reagents for the PacBio Sequel IIe long-read DNA/RNA sequencer. The award is for a firm fixed-price of $46,341.66, with a period of performance through May 30, 2025. Pacific Biosciences is the original equipment manufacturer for the...
- This is a purchase order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. The contract is for $138,848.00 and is a firm fixed price agreement. The contract provides Pacific Biosciences, a manufacturer of scientific equipment, reagents, and services, the opportunity to deliver their proprietary Sequel and Sequel II DNA/RNA sequencing systems, along with associated consumables and software, to...
- This is a $46,512 firm-fixed price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of reagents and consumables compatible with the FDA's PacBio Revio DNA/RNA sequencing instrument. The award is the result of a small business set-aside solicitation for these specialized sequencing supplies to support the FDA National Center for Toxicological Research's (NCTR) error-corrected...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of scientific equipment and reagents, for the provision of their Sequel and Sequel II DNA/RNA sequencing systems and associated consumables. The contract has a potential value of $197,441.19 and a completion date of October 12, 2017. Pacific Biosciences has fulfilled over $10 million in federal contracts with...
- The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- This is a $505,454 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer of advanced DNA sequencing systems and reagents. The contract is for the delivery of a "REAL TIME DNA SEQUENCER" and is set aside for small business. Pacific Biosciences specializes in their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized by various federal...